Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Spangenthal · SciRah

Researcher profile · Semantic Scholar

S. Spangenthal

Share profile

S. Spangenthal — researcher profile on SciRah

h-index: 13
Works: 24
Citations: 618

Most-cited papers

Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial.
Gary T. Ferguson, J. M. Fitzgerald, Eugene R. Bleecker, M. Laviolette +59 more
2017The Lancet Respiratory Medicine109 citations
Semantic Scholar
Efficacy and Safety of Glycopyrrolate/Formoterol Metered Dose Inhaler Formulated Using Co‐Suspension Delivery Technology in Patients With COPD
F. Martinez, K. Rabe, G. Ferguson, L. Fabbri +15 more
2017Chest109 citations Open access
Semantic Scholar
Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial
K. Hardt, A. Vandebosch, J. Sadoff, Mathieu le Gars +284 more
2022Lancet. Infectious Diseases (Print)65 citations Open access
Semantic Scholar
Safety and tolerability of NVA237, a once-daily long-acting muscarinic antagonist, in COPD patients.
C. Vogelmeier, C. Verkindre, D. Cheung, J. Galdiz +6 more
2010Pulmonary Pharmacology & Therapeutics62 citations
Semantic Scholar
Treatment of Persistent Cough in Subjects with Idiopathic Pulmonary Fibrosis (IPF) with Gefapixant, a P2X3 Antagonist, in a Randomized, Placebo-Controlled Clinical Trial
F. Martinez, A. Afzal, Jaclyn Smith, A. Ford +22 more
2021Pulmonary Therapy44 citations Open access
Semantic Scholar
The Role of Guaifenesin in the Management of Chronic Mucus Hypersecretion Associated with Stable Chronic Bronchitis: A Comprehensive Review.
J. Ohar, J. Donohue, S. Spangenthal
2019Chronic obstructive pulmonary diseases41 citations Open access
Semantic Scholar
Faster onset of action of formoterol versus salmeterol in patients with chronic obstructive pulmonary disease: a multicenter, randomized study.
C. Côté, J. Pearle, A. Sharafkhaneh, S. Spangenthal
2009Pulmonary Pharmacology & Therapeutics41 citations
Semantic Scholar
A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease
C. Reisner, L. Fabbri, E. Kerwin, C. Fogarty +12 more
2017Respiratory Research26 citations Open access
Semantic Scholar
Safety and Tolerability of Inhaled Loxapine in Subjects with Asthma and Chronic Obstructive Pulmonary Disease—Two Randomized Controlled Trials
N. Gross, L. Greos, E. Meltzer, S. Spangenthal +3 more
2014Journal of Aerosol Medicine25 citations Open access
Semantic Scholar
Efficacy and safety of twice-daily glycopyrrolate in patients with stable, symptomatic COPD with moderate-to-severe airflow limitation: the GEM1 study
C. Laforce, G. Feldman, S. Spangenthal, Joerg H. Eckert +3 more
2016International Journal of COPD19 citations Open access
Semantic Scholar
Dose-response to inhaled glycopyrrolate delivered with a novel Co-Suspension™ Delivery Technology metered dose inhaler (MDI) in patients with moderate-to-severe COPD
L. Fabbri, E. Kerwin, S. Spangenthal, G. Ferguson +10 more
2016Respiratory Research18 citations Open access
Semantic Scholar
Novel Combination Of Glycopyrrolate And Formoterol MDI (GFF-MDI) Provides Superior Bronchodilation Compared To Its Components Administered Alone, Tiotropium DPI, And Formoterol DPI In A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study In Patients With COPD
C. Reisner, C. Fogarty, S. Spangenthal, L. Dunn +6 more
2011Asian Test Symposium18 citations
Semantic Scholar
Randomized study of the effects of Aerochamber Plus® Flow-Vu® on the efficacy, pharmacokinetics and safety of glycopyrronium/formoterol fumarate dihydrate metered dose inhaler in patients with chronic obstructive pulmonary disease.
F. Fakih, S. Spangenthal, B. Sigal, P. Darken +5 more
2018Respiratory Medicine15 citations Open access
Semantic Scholar
A randomized, controlled, repeat-dose study of batefenterol/fluticasone furoate compared with placebo in the treatment of COPD
Courtney Crim, M. Gotfried, S. Spangenthal, M. Watkins +4 more
2020BMC Pulmonary Medicine11 citations Open access
Semantic Scholar
ELLIPTA Versus DISKUS plus HandiHaler in COPD: A Randomized, Open-Label, Crossover Study in a Clinical Trial Setting.
E. Kerwin, S. Spangenthal, M. Zvarich, Valerie Millar +3 more
2020Chronic obstructive pulmonary diseases6 citations Open access
Semantic Scholar
Efficacy and Safety of Glycopyrrolate/Formoterol MDI Formulated using Co-Suspension™ Delivery Technology in Patients with COPD.
F. Martinez, K. Rabe, G. Ferguson, L. Fabbri +15 more
20165 citations
Semantic Scholar
A phase IIb randomized, chronic-dosing, incomplete block, cross-over study of glycopyrronium, delivered via metered dose inhaler, compared with a placebo and an active control in patients with moderate-to-severe COPD
E. Kerwin, S. Spangenthal, C. Kollar, E. St Rose +1 more
2018Respiratory Research3 citations Open access
Semantic Scholar
Guaifenesin as Adjunctive Therapy in Chronic Cough: A Case Study
S. Spangenthal
2019B60. PULMONARY REHABILITATION: GENERAL1 citations
Semantic Scholar
Once-daily indacaterol 75 μg in moderate- to-severe COPD: results of a Phase IV study assessing time until patients’ perceived onset of effect
T. Siler, C. Laforce, F. Kianifard, James D. Williams +1 more
2014International Journal of COPD1 citations Open access
Semantic Scholar
Erratum to: A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease
C. Reisner, L. Fabbri, E. Kerwin, C. Fogarty +12 more
2017Respiratory Research0 citations Open access
Semantic Scholar
Glycopyrronium Improved Health Status, Dyspnea, and Reduced Rescue Medication Use in Patients With Moderate-to-Severe COPD: Pooled Analysis From GEM1 and GEM2 Studies
C. Laforce, E. Kerwin, S. Spangenthal, P. D'Andrea +3 more
20150 citations
Semantic Scholar
Glycopyrronium Demonstrates Significant Improvements in Lung Function in Patients With Moderate-to-Severe COPD: Pooled Analysis From the GEM1 and GEM2 Studies
E. Kerwin, S. Spangenthal, S. Miller, P. D'Andrea +3 more
20150 citations Open access
Semantic Scholar
Once-daily indacaterol 75 µ g in moderate-to-severe COPD: results of a Phase IV study assessing time until patients’ perceived onset of effect
T. Siler, C. Laforce, F. Kianifard, James D. Williams +1 more
20140 citations
Semantic Scholar
FORMOTEROL HAS A FASTER ONSET OF ACTION THAN SALMETEROL IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
C. Côté, J. Pearle, A. Sharafkhaneh, S. Spangenthal +1 more
20080 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

E. Kerwin×8
Invite
E. Kerwin — researcher profile on SciRah
C. Reisner×8
Invite
C. Reisner — researcher profile on SciRah
P. Darken×6
Invite
P. Darken — researcher profile on SciRah
C. Laforce×5
Invite
C. Laforce — researcher profile on SciRah

×5

Invite

F. Martinez — researcher profile on SciRah

Invite

G. Ferguson — researcher profile on SciRah

Invite

L. Fabbri — researcher profile on SciRah

Tracy L. Fischer×5

Invite

Tracy L. Fischer — researcher profile on SciRah

Invite

M. Golden — researcher profile on SciRah

Invite

C. Orevillo — researcher profile on SciRah

Invite

E. St Rose — researcher profile on SciRah

Invite

G. Feldman — researcher profile on SciRah